Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannabis space with several potential catalysts of note ahead.

4 Things Cannabis Investors Should Watch This Week

Not long ago, the company's prospects were grim. Now TLRY stock is a darling of Wall Street.

Tilray Stock Has Shown Lots of Progress, but the Valuation Is Frothy

SNDL Inc.

Marijuana stocks have outpaced the broader market so far this year and the gains could continue as retail investors pile in. The post 4 Marijuana Stocks That Are Surging appeared first on InvestorPlace.

4 Marijuana Stocks That Are Surging

Aphria

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Michael Auerbach returns to discuss Subversive's recent deal with leading Israeli cannabis company, InterCure, and gives an update on The Parent Company. Why Subversive pivoted from a REIT to a SPAC, Canndoc's compelling financials, brands and trading on Nasdaq.

SPAC Week II: Canndoc And The Parent Company (Podcast Transcript)

The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jessica Rabe discussed what drove the early 2021 cannabis stock rally and three reasons why it has run out of steam in the past two weeks.

3 Reasons Cannabis Stocks May Be Headed Lower

After achieving EBITDA positivity and with an upcoming merger with Aphria, Tilray is poised to do well in the coming year. The post Tilray Will Be the Largest Cannabis Company Once It Merges With Aphria appeared first on InvestorPlace.

Tilray Will Be the Largest Cannabis Company Once It Merges With Aphria

Arena Pharmaceuticals

GW Pharmaceuticals

HEXO Corp

New Age Beverages

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

9 Red-Hot Cannabis Stocks Blazing This Week

Both are high-flying Canadian pot stocks. But one appears to have a clear edge.

Better Cannabis Stock: Sundial Growers vs. Tilray

Analysts say the marijuana producer's shares may have come too far, too fast.

Why Tilray Stock Plunged Today

Jazz Pharmaceuticals

Village Farms International

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Should You Invest in Marijuana Stocks & ETFs Now?

Brendan Kennedy, CEO of cannabis giant Tilray Inc. (NASDAQ:TLRY), posted a letter to his employees after the company hosted its most recent earnings call.  In the letter, Kennedy emphasized the 26% revenue spike in 2020 (compared to 2019) and reiterated that the Nanaimo, Canada-based company is ripe for growth once it wraps up its

Tilray CEO Touts Many 'Cannabis Firsts' In Glowing Letter To Employees After Earnings Call

An earnings beat and beaten down share price add value to a well-placed vertical strategy in TLRY stock for investors. The post Why and How to Buy a Tilray Earnings Beat appeared first on InvestorPlace.

Why and How to Buy a Tilray Earnings Beat

Tilray Inc. shares fell on Thursday, as analysts weighed in on the company's latest quarterly earnings with most looking ahead to the company's pending merger with Aphria Inc., saying Tilray looks less compelling on its own.

Cannabis Watch: Tilray stock loses steam as analysts say company not compelling as stand-alone business, look to Aphria deal

Canadian cannabis companies Tilray Inc. (NASDAQ: TLRY) and Aphria Inc. (NASDAQ: APHA) have agreed to a merger. Meanwhile, Tilray announced strong fourth-quarter results, with meaningful revenue growth and margin expansion.

Tilray Analysts On The Sidelines Despite Solid Earnings

Despite its epic pop and subsequent drop, the story of pot play TLRY stock hasn't changed much, so don't buy the shares for now. The post Don't Get Too Excited About Tilray Stock appeared first on InvestorPlace.

Don't Get Too Excited About Tilray Stock

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

U.S. companies are overlooked by many investors. But any state and federal legalization favors them over Canadian rivals, fund managers say.

Cannabis Watch: If you want to get rich with marijuana stocks, you need to know the crucial difference between U.S. and Canadian companies

Twilio

Walmart

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Here's Why Twilio, Walmart, Tilray, Aphria Are Moving

The Canadian cannabis producer delivered a much-improved performance.

3 Reasons to Give a Big Hooray for Tilray After Its Q4 Update

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q4 2020 Results - Earnings Call Transcript

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 42.86% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Tilray, Inc. (TLRY) Reports Q4 Loss, Tops Revenue Estimates

Cannabis giant Tilray Inc. (NASDAQ: TLRY) saw revenue climb to $210.5 million in 2020. That's a 26% spike compared to what the Nanaimo, Canada-based company reported for 2019.

Tilray Reports 26% Revenue Spike For 2020, Plans To Close Aphria Deal In Q2

Tilray Inc. narrowed losses and boosted revenue in the final three months of 2020, as it prepared to merge with fellow Canadian marijuana company Aphria Inc.

Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today reported financial results for the full fiscal year and fourth quarter ended December 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Brendan Kennedy, Tilray's Chief Executive Officer, stated, “Over the course of 2020, and despite COVID-19 rela

Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results

Canadian cannabis stocks have surged in 2021 and a few of them have exhibited irrational exuberance such as Tilray and Sundial. U.S. cannabis stocks continue to trade at a substantial discount despite possessing significantly stronger fundamentals.

Tilray, Sundial May Be In A Bubble But This Group Remains Attractive

Investors appear to be a little jittery about Tilray's fourth-quarter update later today.

Why Aphria and Tilray Stocks Are Falling Today

News for Tilray Brands Stock (TLRY)